| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |